Read the original post:
Allogene Therapeutics Announces Q2 Investor Conference Participation
Lisata Therapeutics Announces U.S. FDA Orphan Drug Designation Granted to LSTA1 for the Treatment of Osteosarcoma
Curium Announces First Commercial Dose in the Netherlands of PYLCLARI® – an Innovative 18F-PSMA PET Tracer Indicated in Patients With Prostate…
Virbac : Declaration of the number of shares and voting rights 03/2024
Continue reading here:
Virbac : Declaration of the number of shares and voting rights 03/2024
Cogent Biosciences Presents Data Highlighting Potential Best-in-Class Potency and Selectivity of Novel, EGFR Sparing, CNS-Penetrant ErbB2 Inhibitor
Scilex Holding Company Announces Launching of Co-Pay Programs for Both ZTlido® and ELYXYB® for Commercially Insured Patients and the addition of…
Epic Bio Announces Robust Slate of Presentations at the American Society of Gene & Cell Therapy (ASGCT) 27th Annual Meeting
Harvard Bioscience Announces Action to Improve Operational Efficiency and Support Ongoing Investments in Growth
Monthly information related to total number of voting rights and shares composing the share capital – March 29, 2024
Nicox: 2024 Ordinary and Extraordinary Shareholder Meeting
See the original post here:
Nicox: 2024 Ordinary and Extraordinary Shareholder Meeting
QIAGEN N.V. to release results for Q1 2024 and hold webcast
See the original post here:
QIAGEN N.V. to release results for Q1 2024 and hold webcast
IMM-1-104 is Synergistic with Chemotherapy in Pancreatic Cancer Models
View original post here:
IMM-1-104 is Synergistic with Chemotherapy in Pancreatic Cancer Models
RAPT Therapeutics Announces Promising Results from Phase 2 Trial of Tivumecirnon in Combination with Anti-PD-1 Immunotherapy in CPI-Experienced Head…
Imugene’s oncolytic virotherapy VAXINIA and B cell immunotherapy HER-Vaxx featured at the AACR Annual Meeting 2024
IO Biotech Presents New Data at AACR 2024 Further Supporting Dual Mechanism of Action of Lead Cancer Vaccine, IO102-IO103
EUROAPI streamlines its Executive Committee to improve focus and efficiency
Medicenna Presents Updated Preclinical Data on MDNA113, a First-in-Class, Targeted and Masked Bi-functional anti-PD1-IL2 Superkine, at the 2024 Annual…
Clene Announces Peer-Reviewed Publication Characterizing the Protein Corona of the Investigational Neurodegenerative Disease Drug, CNM-Au8®
Cognition Therapeutics to Report Fourth Quarter and Full Year 2023 Results
Here is the original post:
Cognition Therapeutics to Report Fourth Quarter and Full Year 2023 Results
Inc.’s 2024 Female Founders list highlights why female founders are always a good bet
Go here to read the rest:
Inc.’s 2024 Female Founders list highlights why female founders are always a good bet